LANGER DENNIS

CIK 000127422511 companiesASHBURN, VA

SEC Profile

Transactions

Companies

Filings

CIK

0001274225

Recent Transactions

50 trades

Award
Quoin Pharmaceuticals, Ltd.$QNRX
Share Option (Right to Buy)
2026-02-04+21,709→ 21,709 total
Purchase
Quoin Pharmaceuticals, Ltd.$QNRX
Series H Warrants (Right to Buy)
2025-10-14+15,152→ 15,152 total
Purchase
Quoin Pharmaceuticals, Ltd.$QNRX
Series J Warrants (Right to Buy)
2025-10-14+15,152→ 15,152 total
Purchase
Quoin Pharmaceuticals, Ltd.$QNRX
Series K Warrants (Right to Buy)
2025-10-14+15,152→ 15,152 total
Purchase
Quoin Pharmaceuticals, Ltd.$QNRX
ADSs
2025-10-14$8.49/sh+15,152→ 15,153 total
Purchase
Quoin Pharmaceuticals, Ltd.$QNRX
Series I Warrants (Right to Buy)
2025-10-14+15,152→ 15,152 total
Award
Quoin Pharmaceuticals, Ltd.$QNRX
Share Option (Right to Buy)
2025-08-21+13,682→ 13,682 total
Award
Quoin Pharmaceuticals, Ltd.$QNRX
Share Option (Right to Buy)
2025-05-29+7,760→ 7,760 total
Award
Quoin Pharmaceuticals, Ltd.$QNRX
Share Option (Right to Buy)
2024-12-09+50,714→ 50,714 total
Sale
Quoin Pharmaceuticals, Ltd.$QNRX
Ordinary Shares
2024-06-07$0.73/sh−297→ 53 total
Award
Quoin Pharmaceuticals, Ltd.$QNRX
Share Option (Right to Buy)
2023-10-26+7,652→ 7,652 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2022-06-02+17,275→ 106,802 total
Award
Ernexa Therapeutics Inc.$ERNA
Stock Option
2021-12-08+67,000→ 67,000 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2021-08-03−30,000→ 0 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-03$34.75/sh−30,000→ 89,527 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-03$25.39/sh+30,000→ 119,527 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2021-06-03+12,848→ 89,527 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2020-12-04+15,889→ 76,679 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2019-12-05+11,687→ 60,790 total
Award
Dicerna Pharmaceuticals Inc
Director Stock Option (right to buy)
2019-06-20+25,000→ 25,000 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2018-11-29+9,360→ 49,103 total
Sale
Dicerna Pharmaceuticals Inc
Common Stock
2018-08-15$16.00/sh−14,531→ 29,064 total
Sale
Dicerna Pharmaceuticals Inc
Common Stock
2018-08-15$16.00/sh−23,810→ 47,978 total
Award
Dicerna Pharmaceuticals Inc
Director Stock Option (right to buy)
2018-06-21+25,000→ 25,000 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2018-06-08$21.29/sh+13,664→ 53,407 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2018-06-08−13,664→ 0 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2018-06-08$39.35/sh−13,664→ 39,743 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2018-06-07$39.35/sh−3,096→ 39,743 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2018-06-07$21.29/sh+3,096→ 42,839 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2018-06-07−3,096→ 13,664 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2018-06-06$21.29/sh+3,609→ 43,352 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2018-06-06$39.37/sh−3,609→ 39,743 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2018-06-06−3,609→ 16,760 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2018-06-05$39.90/sh−1,227→ 39,743 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2018-06-05$21.29/sh+1,227→ 40,970 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2018-06-05−1,227→ 20,369 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2018-06-04−8,404→ 21,596 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2018-06-04$39.90/sh−8,404→ 39,743 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2018-06-04$39.90/sh−10,000→ 39,743 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2018-06-04$24.39/sh+10,000→ 49,743 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2018-06-04$21.29/sh+8,404→ 48,147 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2018-06-04−10,000→ 0 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2018-06-01$38.90/sh−30,000→ 39,743 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2018-06-01−30,000→ 0 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2018-06-01$24.40/sh+30,000→ 69,743 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2018-05-30−10,000→ 10,000 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2018-05-30$37.92/sh−10,000→ 39,743 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2018-05-30$24.39/sh+10,000→ 49,743 total
Award
PERNIX THERAPEUTICS HOLDINGS, INC.
Stock Option (right to buy)
2018-05-22+25,000→ 25,000 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2018-05-21$35.90/sh−10,000→ 20,000 total

Companies

Recent Filings

Address

C/O QUOIN PHARMACEUTICALS LTD., 42127 PLEASANT FOREST COURT

ASHBURN, VA, 20148

View on SEC.gov